Skip to main content
logo
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.465
-0.015 (-0.43%)
Aug 3, 2026, 11:36 AM EDT - Market open

C4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Market Cap
383185254---
Market Cap Growth
149.79%-27.20%----
Enterprise Value
174.95-3.4575.11000
Last Close Price
3.471.913.605.9032.2033.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
PS Ratio
11.045.157.15---
PB Ratio
1.550.721.18---
P/TBV Ratio
1.540.621.161.003.811.34

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
5.02-0.102.11---
EV/EBITDA Ratio
-0.03----
EV/EBIT Ratio
-0.03----
EV/FCF Ratio
-0.03----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.220.210.280.280.110.08
Net Debt / Equity Ratio
-0.76-0.73-0.83-0.65-0.68-1.24
Net Debt / EBITDA Ratio
-1.671.521.483.305.93
Net Debt / FCF Ratio
-1.902.741.703.025.14
Asset Turnover
-0.100.100.070.100.13
Quick Ratio
8.757.605.496.236.158.58
Current Ratio
9.007.815.716.466.368.69
Return on Equity (ROE)
--44.38%-48.70%-37.76%-25.03%-33.95%
Return on Assets (ROA)
--32.52%-34.21%-27.63%-18.11%-23.10%
Return on Invested Capital (ROIC)
--219.74%-174.53%-115.95%-297.44%-
Return on Capital Employed (ROCE)
--36.55%-39.29%-30.78%-20.23%-27.42%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Buyback Yield / Dilution
-38.20%-19.49%-41.98%-6.12%-304.93%-728.80%
Total Shareholder Return
-38.20%-19.49%-41.98%-6.12%-304.93%-728.80%
SEC Filings: 10-K · 10-Q